Clinical Trial Update: Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rifampin to isoniazid for latent tuberculosis infection in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• ISONIAZID (ISONIAZID)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: McGill University | Conditions: Latent Tuberculosis Infection | Phase 3 | Status: COMPLETED